» Articles » PMID: 37975646

Disseminating Cells in Human Oral Tumours Possess an EMT Cancer Stem Cell Marker Profile That is Predictive of Metastasis in Image-based Machine Learning

Overview
Journal Elife
Specialty Biology
Date 2023 Nov 17
PMID 37975646
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition (EMT) to drive metastatic dissemination in experimental cancer models. However, tumour cells undergoing EMT have not been observed disseminating into the tissue surrounding human tumour specimens, leaving the relevance to human cancer uncertain. We have previously identified both EpCAM and CD24 as CSC markers that, alongside the mesenchymal marker Vimentin, identify EMT CSCs in human oral cancer cell lines. This afforded the opportunity to investigate whether the combination of these three markers can identify disseminating EMT CSCs in actual human tumours. Examining disseminating tumour cells in over 12,000 imaging fields from 74 human oral tumours, we see a significant enrichment of EpCAM, CD24 and Vimentin co-stained cells disseminating beyond the tumour body in metastatic specimens. Through training an artificial neural network, these predict metastasis with high accuracy (cross-validated accuracy of 87-89%). In this study, we have observed single disseminating EMT CSCs in human oral cancer specimens, and these are highly predictive of metastatic disease.

Citing Articles

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.


Single-Cell RNA-Seq Analysis Reveals the Acquisition of Cancer Stem Cell Traits and Increase of Cell-Cell Signaling during EMT Progression.

Bocci F, Zhou P, Nie Q Cancers (Basel). 2021; 13(22).

PMID: 34830900 PMC: 8616061. DOI: 10.3390/cancers13225726.


Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.

Jia W, Tripathi S, Chakraborty P, Chedere A, Rangarajan A, Levine H Oncotarget. 2020; 11(27):2611-2624.

PMID: 32676163 PMC: 7343638. DOI: 10.18632/oncotarget.27651.

References
1.
Ocana O, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S . Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012; 22(6):709-24. DOI: 10.1016/j.ccr.2012.10.012. View

2.
Biddle A, Gammon L, Liang X, Costea D, Mackenzie I . Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma. EBioMedicine. 2016; 4:138-45. PMC: 4776071. DOI: 10.1016/j.ebiom.2016.01.007. View

3.
Li W, Kang Y . Probing the Fifty Shades of EMT in Metastasis. Trends Cancer. 2016; 2(2):65-67. PMC: 4815261. DOI: 10.1016/j.trecan.2016.01.001. View

4.
Biddle A, Liang X, Gammon L, Fazil B, Harper L, Emich H . Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 2011; 71(15):5317-26. DOI: 10.1158/0008-5472.CAN-11-1059. View

5.
Ruscetti M, Dadashian E, Guo W, Quach B, Mulholland D, Park J . HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 2015; 35(29):3781-95. PMC: 4896852. DOI: 10.1038/onc.2015.444. View